Megan McDevitt
Physician Assistant · Virginia Beach, VANPI 1255733051
Payments from drug & device makers
Across 83 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$316
- Novartis$188
- Amgen$175
- Boehringer Ingelheim$160
- E.r. Squibb & Sons, L.L.C.$118
- Pfizer$93
- plus $515 from 15 others
What the payments were for
- Food & beverage$1,565100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $316 |
| Novartis | 13 | $188 |
| Amgen | 8 | $175 |
| Boehringer Ingelheim | 8 | $160 |
| E.r. Squibb & Sons, L.L.C. | 5 | $118 |
| Pfizer | 5 | $93 |
| Lexicon Pharmaceuticals, Inc. | 3 | $62 |
| Bayer | 3 | $61 |
| AstraZeneca | 3 | $59 |
| Esperion Therapeutics, Inc. | 3 | $54 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $40 |
| Scpharmaceuticals Inc. | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $33 |
| Merck | 2 | $29 |
| Stryker | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Atricure, Inc. | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $20 |
| Medtronic | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
How this compares
$1,565 in reported general payments places this provider in the 75th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 65 | $60,292 |
| EntrestoSacubitril/Valsartan | 18 | $25,473 |
| Repatha SureclickEvolocumab | 14 | $17,731 |
| XareltoRivaroxaban | 22 | $14,379 |
| FarxigaDapagliflozin Propanediol | 11 | $10,080 |
| BrilintaTicagrelor | 12 | $9,647 |
| VascepaIcosapent Ethyl | 11 | $3,743 |
| Icosapent Ethyl | 13 | $2,048 |
| Atorvastatin Calcium | 84 | $878 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 19 | $685 |
| Metoprolol Succinate | 63 | $656 |
| ClopidogrelClopidogrel Bisulfate | 37 | $528 |
| Ezetimibe | 23 | $513 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 18 | $308 |
| Carvedilol | 36 | $301 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $93 | $60,29265 claims |
| NovartisEntresto | $188 | $25,47318 claims |
| AstraZenecaFarxiga, Brilinta | $59 | $19,72723 claims |
| Johnson & JohnsonXarelto | $14 | $14,37922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Virginia Beach
- Jamie GiovanelliVirginia Beach$118K
- Juliette BeristainVirginia Beach$54K
- Chelsea ChristensenVirginia Beach$21K
- Ashton Dear-HuffmanVirginia Beach$14K
- Samantha McCartyVirginia Beach$14K
- Kimberly SilverVirginia Beach$13K
- Timothy JacksonVirginia Beach$12K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- John CarterStaunton$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.